NAD+ is central to research into cellular metabolism and ageing. Anyone who looks into it soon comes across two other abbreviations: NMN and NR. These are not alternatives to NAD+ but precursors: building blocks that the cell itself converts into NAD+. Here you can read how that works and when to use which form.
At a glance
| NAD+ | NMN | NR | |
|---|---|---|---|
| Full name | Nicotinamide adenine dinucleotide | Nicotinamide mononucleotide | Nicotinamide riboside |
| What is it? | The coenzyme itself | Direct precursor | Precursor of NMN |
| Molecular weight | 663.4 g/mol | 334.2 g/mol | 255.2 g/mol (290.7 as chloride) |
| Steps to NAD+ | None | One (NMNAT) | Two (NRK, then NMNAT) |
| Typical research use | In vitro, enzyme assays, cell cultures | Animal and human studies | Animal and human studies |
What does NAD+ do?
NAD+ is a coenzyme found in every cell. It has two main roles. First, it is an electron carrier in energy metabolism: it constantly switches between NAD+ and NADH, delivering electrons to the mitochondria for the production of ATP. Second, it is the fuel for enzymes that consume NAD+: the sirtuins (SIRT1–7), the DNA repair enzymes PARP and the enzyme CD38 [1].
NAD+ levels in human and animal tissues decline with age. Research points mainly to increased consumption, partly by CD38, which becomes more active with age [2].
How the cell makes NAD+
The cell has three pathways for making NAD+:
- De novo pathway from the amino acid tryptophan, a long route through a series of intermediate steps.
- Preiss-Handler pathway from nicotinic acid (niacin, a form of vitamin B3).
- Salvage pathway, the most important one: the nicotinamide released when enzymes consume NAD+ is converted into NMN by the enzyme NAMPT, and NMNAT turns NMN back into NAD+.
NR feeds into that salvage pathway: the enzyme NRK converts NR into NMN, and from there it is one step to NAD+. NMN is therefore one step closer than NR [3].
Why researchers use precursors
NAD+ is a relatively large, charged molecule. Outside the cell it is quickly broken down, partly by CD38 and CD73, into smaller substances such as NMN and NR. Cells take up these smaller precursors more easily and rebuild NAD+ from them inside the cell. That is why studies on raising NAD+ in the body usually use NMN or NR [3].
For other research, NAD+ itself is the logical choice. In enzyme assays with sirtuins or PARPs, in cell-free systems and when measuring the NAD+/NADH ratio, you want to know exactly how much NAD+ is present, without any conversion steps in between.
What do human studies show?
- NR raised NAD+ levels in the blood in several studies, including in healthy older adults. The effects on blood pressure and arterial stiffness were promising in an initial study but not conclusive [4].
- NMN improved muscle insulin sensitivity in a randomised study in women with prediabetes, with no effect on body weight or blood pressure [5].
- NAD+ itself has mainly been studied in humans in small studies using infusion; large controlled studies are lacking.
Overall, raising NAD+ demonstrably works, but the health effects in humans have not yet been clearly established. In addition, NMN is not authorised as a food supplement in the EU (novel food).
Which form should you choose for research?
- You are measuring enzyme activity (sirtuins, PARPs, CD38) or working cell-free: NAD+.
- You are studying the NAD+/NADH balance or mitochondrial function in cell cultures with a known amount of coenzyme: NAD+.
- You are investigating uptake and conversion in living systems: a precursor such as NMN or NR.
NAD+ is sensitive to light and moisture. So also read Storage and stability of lyophilized peptides; the same rules apply here.
Sources
- Covarrubias AJ, Perrone R, Grozio A, Verdin E. NAD+ metabolism and its roles in cellular processes during ageing. Nat Rev Mol Cell Biol. 2021;22(2):119–141.
- Camacho-Pereira J, Tarragó MG, Chini CCS, et al. CD38 Dictates Age-Related NAD Decline and Mitochondrial Dysfunction through an SIRT3-Dependent Mechanism. Cell Metab. 2016;23(6):1127–1139.
- Rajman L, Chwalek K, Sinclair DA. Therapeutic Potential of NAD-Boosting Molecules: The In Vivo Evidence. Cell Metab. 2018;27(3):529–547.
- Martens CR, Denman BA, Mazzo MR, et al. Chronic nicotinamide riboside supplementation is well-tolerated and elevates NAD+ in healthy middle-aged and older adults. Nat Commun. 2018;9(1):1286.
- Yoshino M, Yoshino J, Kayser BD, et al. Nicotinamide mononucleotide increases muscle insulin sensitivity in prediabetic women. Science. 2021;372(6547):1224–1229.
Research Use Only. This article summarises published research and is not medical advice or advice on use. PepPure’s NAD+ is intended exclusively for in-vitro research and laboratory use.